French ExonHit Therapeutics Achieves First Research Milestone in its Collaboration with Allergan
Compound Synthesized at ExonHit Demonstrates Promising Preclinical Profile
14-Dec-2004 -
ExonHit Therapeutics announced that it has reached a first research milestone in its collaboration with Allergan. A new orally active small molecule was synthesized by ExonHit's chemists to modulate a pathway identified by ExonHit's alternative splicing profiling technology, DATAS®, in tissues ...
Allergan
diseases
neuropathic pain
+2